EDITORIAL
Published on 10 Dec 2020
Editorial: Novel Drugs Targeting the Microenvironment and the Epigenetic Changes in Hematopoietic Malignancies
doi 10.3389/fphar.2020.614614
- 1,132 views
- 2 citations
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Novel Drugs Targeting the Microenvironment and the Epigenetic Changes in Hematopoietic Malignancies
Novel Drugs Targeting the Microenvironment and the Epigenetic Changes in Hematopoietic Malignancies
9,569
Total downloads
32k
Total views and downloads
Articles
MINI REVIEW
Published on 09 Jul 2020
Targeting the Microenvironment in MDS: The Final Frontier
doi 10.3389/fphar.2020.01044
- 5,670 views
- 18 citations
ORIGINAL RESEARCH
Published on 30 Jun 2020
Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 Cases
doi 10.3389/fonc.2020.00923
- 7,565 views
- 17 citations
REVIEW
Published on 29 Jun 2020
SERS-Based Assessment of MRD in Acute Promyelocytic Leukemia?
doi 10.3389/fonc.2020.01024
- 4,324 views
- 5 citations
CASE REPORT
Published on 09 Apr 2020
Single-Center Experience With Epigenetic Treatment for Juvenile Myelomonocytic Leukemia
doi 10.3389/fonc.2020.00484
- 3,400 views
- 9 citations
ORIGINAL RESEARCH
Published on 13 Mar 2020
B7-Positive and B7-Negative Acute Myeloid Leukemias Display Distinct T Cell Maturation Profiles, Immune Checkpoint Receptor Expression, and European Leukemia Net Risk Profiles
doi 10.3389/fonc.2020.00264
- 3,414 views
- 12 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore